JCR Pharmaceuticals Co., Ltd.

OTCPK:JCRR.F Stock Report

Market Cap: US$602.6m

JCR Pharmaceuticals Future Growth

Future criteria checks 3/6

JCR Pharmaceuticals is forecast to grow earnings and revenue by 27.2% and 3.3% per annum respectively. EPS is expected to grow by 27.8% per annum. Return on equity is forecast to be 7.7% in 3 years.

Key information

27.2%

Earnings growth rate

27.8%

EPS growth rate

Pharmaceuticals earnings growth23.9%
Revenue growth rate3.3%
Future return on equity7.7%
Analyst coverage

Good

Last updated26 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:JCRR.F - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202741,8035,0564,1816,6677
3/31/202641,3194,6197,5407,2437
3/31/202541,5144,600-2,33011,7047
9/30/202435,256-4374334,682N/A
6/30/202440,2084,098N/AN/AN/A
3/31/202442,8715,5077,2179,312N/A
12/31/202341,3655,364N/AN/AN/A
9/30/202343,0348,063-9,017-952N/A
6/30/202335,5454,014N/AN/AN/A
3/31/202334,3433,772-14,060-5,500N/A
12/31/202237,5085,154N/AN/AN/A
9/30/202238,2806,2354,85713,009N/A
6/30/202250,87514,343N/AN/AN/A
3/31/202251,08214,507-2,0449,289N/A
12/31/202150,93116,549N/AN/AN/A
9/30/202147,51714,899-6,4951,362N/A
6/30/202134,7177,657N/AN/AN/A
3/31/202130,0856,8922,81410,341N/A
12/31/202026,1284,137N/AN/AN/A
9/30/202024,4962,9831,0406,210N/A
6/30/202024,8073,076N/AN/AN/A
3/31/202024,7812,678894,927N/A
12/31/201925,7093,653N/AN/AN/A
9/30/201924,1213,260114,482N/A
6/30/201923,6383,802N/AN/AN/A
3/31/201923,1603,7153,0103,905N/A
12/31/201820,8742,454N/AN/AN/A
9/30/201820,6822,5662,7103,675N/A
6/30/201820,8852,857N/AN/AN/A
3/31/201820,5943,070N/A3,133N/A
12/31/201720,2332,930N/AN/AN/A
9/30/201719,7382,722N/A2,572N/A
6/30/201718,6702,079N/AN/AN/A
3/31/201718,0851,863N/A2,651N/A
12/31/201617,4831,668N/AN/AN/A
9/30/201617,1901,751N/A1,017N/A
6/30/201617,0911,620N/AN/AN/A
3/31/201617,4381,789N/A2,201N/A
12/31/201517,5942,299N/AN/AN/A
9/30/201517,4822,281N/A2,853N/A
6/30/201517,1921,861N/AN/AN/A
3/31/201516,8551,682N/A499N/A
12/31/201416,3801,066N/AN/AN/A
9/30/201416,5161,319N/A2,795N/A
6/30/201416,1171,316N/AN/AN/A
3/31/201415,7051,296N/A4,565N/A
12/31/201315,6691,517N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: JCRR.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: JCRR.F is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: JCRR.F is expected to become profitable in the next 3 years.

Revenue vs Market: JCRR.F's revenue (3.3% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: JCRR.F's revenue (3.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: JCRR.F's Return on Equity is forecast to be low in 3 years time (7.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y